Though many mock trials and focus groups have been put on pause in hopes of safely resuming to business as usual, we’re finding that some jurisdictions won’t be suitable for in-person research for quite some time. Yet, trial dates loom… Read More
Blog
-
Meaningful Corporate Actions: Juror Attitudes Toward Corporations in the Time of COVID-19 – Part 2
As the COVID-19 outbreak progressed, the public eye focused in part on corporate actions: How were corporations responding to the weak economy? How were they treating employees who could no longer work in-person? Were they doing anything to help in… Read More
-
Concerning Corporations: Juror Attitudes Toward Corporations in the Time of COVID-19 – Part 1
I can understand why someone would come in predisposed against big corporations, because they are in the limelight more and more these days, with things like corruption from the higher-ups. I used to believe authority is always right. I trusted… Read More
-
How Can My Corporate Representative Battle Jurors’ Decreased Trust in Big Business?
Every year, Dictionary.com chooses a word of the year based on the current cultural climate and increased searches on its website. In 2018, the website chose the word ‘misinformation,’ to highlight increasing concerns regarding the spread of misleading or false… Read More
-
Has COVID-19 Affected Jurors’ Trust in Government Agencies and Safety Standards? – Part 2
As discussed in Part 1, Litigation Insights’ national survey1 on the federal government and the Centers for Disease Control and Prevention (CDC), the Environmental Protection Agency (EPA), the Food and Drug Administration (FDA), and the Occupational Safety and Health Administration… Read More
-
Has COVID-19 Affected Jurors’ Trust in Government Agencies and Safety Standards? – Part 1
Corporate defendants often rely on government safety standards for product safety, services, and workplace procedures. In litigation, standards from the Centers for Disease Control and Prevention (CDC), the Environmental Protection Agency (EPA), the Food and Drug Administration (FDA), and the… Read More
-
Tips for Defending Consolidated Cases
The Perils of Multi-Plaintiff Trials Even prior to the COVID-19 pandemic, judges across jurisdictions struggled to balance busy dockets and address their mounting caseloads. The consolidation of cases, particularly in the mass tort arena, has been one tool that judges… Read More
-
When Can Reframing Create Juror Backlash?
Say you represent a company that makes a product people widely have negative opinions about. Luckily, you come up with a different description of the product that makes it sound more positive: For example, your client is in the vaping… Read More
-
How Do You Combat Confirmation Bias?
“I’ve just heard too many stories about corporations trying to profit at the expense of the ‘little guy.’” “Everyone sues for everything nowadays. There are too many frivolous lawsuits.” The greedy corporation. The sue-happy plaintiff. If all the world’s a… Read More